Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS)

CUSIP: 03753U106

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
125,684,656
Total 13F shares
55,273,539
Share change
+11,351,960
Total reported value
$1,482,076,889
Put/Call ratio
312%
Price per share
$26.79
Number of holders
143
Value change
+$294,686,642
Number of buys
94
Number of sells
57

Quarterly Holders Quick Answers

What is CUSIP 03753U106?
CUSIP 03753U106 identifies APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) as of Q1 2020

As of 31 Mar 2020, Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,273,539 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., HILLHOUSE CAPITAL ADVISORS, LTD., VANGUARD GROUP INC, STATE STREET CORP, Cormorant Asset Management, LP, JENNISON ASSOCIATES LLC, FARALLON CAPITAL MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, and MILLENNIUM MANAGEMENT LLC. This page lists 143 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.